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Abstract
Directed evolution can generate a remarkable range of new enzyme properties. Alternate substrate
specificities and reaction selectivities are readily accessible in enzymes from families that are
naturally functionally diverse. Activities on new substrates can be obtained by improving variants
with broadened specificities or by step-wise evolution through a sequence of more and more
challenging substrates. Evolution of highly specific enzymes has been demonstrated, even with
positive selection alone. It is apparent that many solutions exist for any given problem, and there
are often many paths that lead uphill, one step at a time.
Introduction
Directed evolution is now well established as highly effective for protein engineering and
optimization. Directed evolution entails accumulation of beneficial mutations in iterations of
mutagenesis and screening or selection; it can be thought of as an uphill climb on a `fitness
landscape', a multidimensional plot of fitness versus sequence. Fitness in a directed
evolution experiment - how the protein performs the target function under the desired
conditions - is defined by the experimenter, who also controls the relationship between
fitness and reproduction. There are an enormous number of ways to mutate any given
protein: for a 300-amino acid protein there are 5700 possible single amino acid substitutions
and already 32,381,700 ways to make just two substitutions. The number of ways to make
four substitutions is bigger than the US national debt, a very large number indeed. Because
most mutational paths lead downhill and eventually to unfolded, useless proteins (there are
far many more ways to make a useless protein than a useful one), the challenge lies in
identifying an efficient path to the desired function.
With accumulating evolutionary enzyme engineering experience and particularly owing to
studies in which the results of evolution, both natural and directed, have been dissected to
identify the adaptive mutations and possible pathways of their accumulation [1-3,4•], it is
becoming clear that (1) multiple solutions are often accessible for any given functional
problem and (2) there is usually a pathway whereby the target property can be acquired in a
series of single, individually beneficial amino acid mutations. Whereas negative epistatic
effects (in which a combination of mutations is beneficial although at least one individual
mutation is not) are pervasive in natural evolution [5,6], there is little evidence that such
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effects have played a major role in facilitating directed evolution. The vast majority of
evolutionary engineering studies over the past ten years involve simple uphill walks, one
step at a time. Recent work reviewed here shows that the simple uphill walk can go to quite
interesting places!
Functional characterization of intermediates along evolutionary pathways has also
highlighted how the acquisition of activity on new substrates often proceeds through
enzymes that accept a much broader range of substrates [7]. Studies also continue to show
that subsequent re-specialization of these `generalists' is possible. Finally, it is increasingly
clear that the natural history of an enzyme is a good indicator of its evolvability [8]:
enzymes from large families exhibiting diverse functions or broad substrate ranges are easy
to evolve in the laboratory. The same mechanisms leading to their natural functional
diversity facilitate the acquisition of new functions in the laboratory.
There are many ways to create sequence diversity, and this is an important part of the search
strategy for molecular optimization. The goal in choosing a mutagenesis strategy is to
minimize the screening requirement and increase the chances of finding beneficial mutations
[9•]. There is no single `best'mutagenesis method. Because there are many paths to a given
goal, multiple methods will work (although some are far more efficient than others).
Methods for generating diversity and advances in selection and screening methods for
enzymes have been reviewed recently [10-12] and are also covered elsewhere in this issue.
Here we will limit our discussion to a few selected topics where recent literature has made
significant advances in our understanding and practice of directed enzyme evolution.
Promiscuous intermediates and the importance of natural history
Evolution has created numerous specialized enzymes that function in living cells to catalyze
the chemical reactions of life. Their specificity is tuned so that they generally do not tread on
each other's toes. But that does not mean their specificity is absolute: a recurring observation
has been that many enzymes have weak activity on non-native substrates and that directed
evolution can amplify these weak activities. When the desired activity is not measurable in
the wild-type enzyme, it may be possible to find it in close variants that have been evolved
for activity on other substrates [13] or even in enzymes that have been evolved neutrally,
accumulating mutations that do not significantly damage the native activity [14,15]. These
mutated enzymes tend to exhibit broader functional ranges, possibly through degradation of
specific interactions with the natural substrate and conferring the ability to bind multiple
substrates [8].
Experience indicates that changing the activities of enzymes for which there already exists
functional diversity in nature is easier than for enzymes that tend to have very specific
functions across many species. Diversifying function is `easy' if there are multiple single-
amino acid substitutions that do it. Enzymes involved in secondary metabolite formation, for
example, are often quite promiscuous in their substrate specificities and reaction selectivities
[16]. They are also highly evolvable: single amino acid substitutions in carotenoid
biosynthetic enzymes - synthases, desaturases, cyclases, and oxygenases - alter both
substrate specificity and reaction selectivity to produce a variety of novel carotenoids [17].
O'Maille et al.[18••] analyzed the catalytic landscape between a sesquiterpene synthase and
its functionally orthogonal homolog (75% identity) by investigating a large fraction of the
512 possible variants having different subsets of the nine amino acid changes known to
inter-convert reaction selectivity (one synthase produces 5-epiaristolochene from farnesyl
diphosphate, while the other produces premnaspirodiene). About half of the sesquiterpene
synthase variants catalyzed the formation of both parental synthase products as well as
several other terpenes, some produced naturally by related synthases. Alternate selectivities
Tracewell and Arnold Page 2
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
were accessible from these intermediate enzymes with as little as a single amino acid
change.
Although amino acid residues that alter substrate selectivity or specificity are often located
in the active site/substrate binding pocket, it is also often observed that mutations conferring
changes in these properties are not. Even distant mutations can significantly affect catalysis
by slightly altering the geometry, electrostatic properties, or dynamics of amino acids in the
active site, which influence the course of a reaction, particularly after a high-energy
intermediate is formed. For example, only two of the nine synthase amino acid residues
investigated in the sesquiterpene synthases were in the active site, with the remainder
scattered throughout the enzyme. Changing just the two in the active site resulted in the
formation of 4-epi-eremophilene, a terpene not normally produced in nature, while changing
two non-active site residues incrementally converted the synthase from a mainly 5-epi-
aristolochene producer to one producing mainly premnaspirodiene. Umeno et al.[17] called
this type of evolvable chemistry `pachinko chemistry', referring to the popular Japanese
game in which the fate of a raised metal ball depends on the precise interactions it has with
small metal pins as it falls down a board.
Other examples of evolvable enzymes include cytochrome P450s [19,20], glutathione
transferases [21], enzymes having the common (β/α)8 barrel scaffold [22,23], and members
of α/β hydrolase-fold families such as esterases and lipases [4•,24,25]. All these families
exhibit wide functional diversity in nature. We have observed anecdotally that obtaining
functional diversity - for example, activity on many new substrates - tends to be more
difficult when the targeted enzyme does not have functionally diverse natural homologs. It is
possible that such enzymes have more specific contacts with their substrates that preclude
functional evolution through single beneficial mutations.
Evolving novel activity
Not long ago engineering a novel activity was considered to be a major challenge for
directed evolution. Whereas engineering catalysts for new reactions is still extremely
challenging, obtaining activity on a new substrate is far less so. If an enzyme does not
already exhibit a desired activity, the difficulty of engineering that activity depends on how
many amino acid substitutions are required to reach it. If even two simultaneous amino acid
substitutions are needed to generate measurable activity, and those mutations are made
randomly, the screening requirement is already very high. The complexity grows
exponentially with the number of required changes. Strategies to overcome this exponential
explosion include (1) converting the big challenge into a series of smaller ones by
incrementally changing the selection pressure to achieve the desired activity (analogous to
increasing temperature slightly in each generation to find highly thermostable enzymes), for
example, by choosing intermediate target substrates that individually represent small hurdles
but lead to the desired activity [26], and (2) creating a `generalist' enzyme, with broader
specificity that includes weak activity toward the desired substrate, and then improving the
activity of that generalist. Directing multiple simultaneous mutations to a smaller set of
amino acid positions in a hybrid `rational'/evolutionary engineering approach is also possible
[9•,27-30], but of course works only if the desired function is encoded by changes in the
targeted sites.
The incremental challenge approach to obtaining a new activity was used by Fasan et al.
[31••], who converted a cytochrome P450 fatty acid hydroxylase into a highly efficient
propane hydroxylase, an activity absent in the native enzyme. They first improved the
existing weak activity on octane until there was sufficient side activity on propane to allow
screening directly on a surrogate of the smaller alkane. The propane hydroxylase they
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obtained has sufficient side activity on ethane to allow screening for hydroxylation of that
substrate.
Early steps in directed evolution for activity on a non-native substrate often create
`generalists' that are active on a much broader range of substrates. These have been used in a
more serendipitous approach to obtaining new activities. For example, a broad-range,
stereoselective D-amino acid dehydrogenase was generated from mesodiaminopimelate D-
hydrogenase [32] with a first round of directed evolution to identify variants that could
accept substrates similar to the native substrate, meso-diaminopimelic acid. One variant had
activity on D-lysine, and additional rounds of evolution further broadened its substrate range
to include straight-chain aliphatic and aromatic amino acids. In another example, galactose
oxidase was initially evolved to increase its activity on D-glucose; one variant had a broader
substrate range that included 1-phenylethanol. Further directed evolution improved its
activity on 1-phenylethanol as well as other secondary alcohols [33].
New activities can also arise during `neutral drifts', in which mutations that do not abolish
the native activity are accumulated in multiple rounds of high-error-rate mutagenesis and
screening [15,34,35]. Similarly, the large number of mutations made by recombination of
homologous glutathione transferases [21] and cytochrome P450s [36] - which can be
thought of as a type of intense neutral drift - led to the emergence of activities not observed
in the parent enzymes.
Enzyme engineers also want to catalyze new reactions, but these are harder to obtain by
directed evolution. This is where rational design can provide a crucial boost by assembling
at least the rudiments of an active site. Recent enzymes designed de novo using
computational methods show both the promise and limitations of the approach (and of our
understanding of enzyme function and ability to translate that into a design) [37•,38].
Reactions for which there are no known counterparts in nature become accessible when the
designed protein binds the transition state with higher affinity than the substrates or
products. Unfortunately, transition state binding is just one piece of the catalysis puzzle, and
the resulting catalysts are not particularly impressive, at least compared to most enzymes.
Directed evolution, however, can take over where rational design necessarily leaves off:
with the fine-tuning. Seven rounds of random mutagenesis, recombination, and screening
improved the kcat/Km of a designed Kemp elimination catalyst >200-fold [37•]. The eight
accumulated amino acid substitutions occurred at positions adjacent to the designed residues
as well as farther from the active site.
Evolving specific enzymes
On rare occasions an enzyme with high specificity for a new substrate can be generated with
a single amino acid substitution [39]. Activity on a new substrate, however, is usually
achieved by broadening the substrate range (Figure 1), which indicates that these `generalist'
enzymes are the most accessible, and frequent, solutions. In fact, there are usually many
ways to obtain low activity on a new substrate [9•,34,36,40•,41]. If a substrate-specific
enzyme is required, it may be possible to eliminate variants that maintain activity on the
native or another undesired substrate using negative selection. Further mutagenesis may also
be required to obtain the desired specificity, with positive selection to improve the desired
activity and negative selection to remove the undesired one(s). Recent examples include
highly active and selective endopeptidases generated using positive and negative selection
with a fluorescent activated cell sorting (FACS) screen [29,30] and a D-xylose-specific
xylose reductase engineered using positive and negative selection for growth or inhibition
on the substrates [42].
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Specificity can also come as a side result of continued pressure for higher activity on the
new substrate when interactions with the new substrate interfere with recognition of the old.
Fasan et al. evolved their highly active propane monooxygenase with positive selection
alone over multiple rounds of mutagenesis and screening for activity on propane [31••]. The
substrate range of this enzyme turned out to be very narrow and no longer included the
native C12-C20 fatty acid substrates, or even octane [43•]. When new activities are obtained
in early generations of directed evolution via a generalist enzyme, these new activities are
usually well below that of the native enzyme on its preferred substrates. Further evolution to
enhance one activity comes at the cost of the others when the substrates differ structurally
and chemically and therefore interact with the enzyme in mutually incompatible ways. The
ease of re-specialization obviously depends on how easily the enzyme can recognize those
differences.
Changing or increasing enzyme enantioselectivity is important for creating biocatalysts for
synthetic organic chemistry [44]. Because the solution to this problem is reconfiguring the
active site to accept (or produce) only one enantiomer, it was anticipated to be difficult to
engineer in enzymes, probably requiring multiple simultaneous mutations. To evolve an
enantioselective lipase, Reetz et al.[4•] initially used random mutagenesis with a high error
rate and then saturation mutagenesis of residues in the active site. The best enantioselective
lipase from that set contained six amino acid mutations. Computational analysis predicted
that only two of these were necessary, and the double variant in fact had greater
enantioselectivity than the variant with all six mutations. Because both mutations
contributed positively to the new phenotype (no negative epistasis), an uphill walk could
have found the double variant, particularly if beneficial mutations were recombined (e.g. by
shuffling) or if several improved mutants were evolved in parallel after the first round.
Directed evolution usually goes through single amino acid improvements
Analysis of the directed evolution literature shows that a wide range of problems can be
solved by uphill walks involving single amino acid changes. Often, single mutations are
responsible for the functional change, even when multiple mutations are made [45]. Or,
when multiple beneficial mutations are found, they all contribute and could have been found
separately, as in the enantioselectivity example discussed above. Analysis of reconstructed
evolutionary intermediates supports these observations by demonstrating that multiple
pathways of small incremental improvements exist [1,2].
Not surprisingly, then, a highly effective and efficient directed evolution strategy is to
gradually accumulate single beneficial mutations, either sequentially or by recombination,
while applying (often increasing) selection pressure. Low error-rate random mutagenesis by
error-prone PCR is very simple to implement, but only accesses a limited set of (mostly
conservative) amino acid changes. Other mutagenesis methods, including saturation
mutagenesis, can effectively generate additional amino acid possibilities in targeted
residues. Such a walk does not require construction and screening of very large libraries: a
few thousand clones can cover much of the single-mutant possibilities in each generation.
With the reduced screening load comes the possibility of using screens that are higher in
quality and more likely to accurately interrogate the desired properties.
An uphill walk via single beneficial mutations works only if (1) intermediates exist along
the path from the starting point to the desired enzyme that incrementally improve the desired
properties, and (2) the path chosen in each generation does not lead to a dead end (Figure 2).
There are effective ways to circumvent apparent dead ends, including incorporation of
stabilizing mutations that allow the accumulation of new functional, but destabilizing
mutations [31••,46]. Natural evolution apparently uses this route, where a `global
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suppressor' mutation that is functionally neutral or even slightly deleterious can make up for
the effects of an adaptive mutation that would otherwise destabilize and destroy the protein
[34]. Another way to circumvent dead ends is to evolve multiple routes in parallel. Multiple
routes can be explored simultaneously by maintaining populations in each round; the
screening requirement scales linearly with the population size. Coupled mutations are not
discovered by this route because the low error-rate in the mutagenesis step simply does not
make them. But, because there are likely to be multiple solutions (sequences) that satisfy a
fitness challenge, and because there are many paths to those solutions, negative epistatic
paths, which definitely exist [47], can simply be bypassed.
When the mutation rate is high, beneficial mutations are quickly masked by the much more
frequent deleterious ones. Low error rates - 1-2 amino acid substitutions per gene - are
therefore preferred if the entire gene is mutated. Statistical methods to identify beneficial
mutations in variants containing multiple mutations have been described [48,49] and allow
simultaneous examination of substitutions at more positions. But, to reliably identify
beneficial ones, one must examine many mutation combinations [49] or make tailored sets
of sequences where mutations are represented approximately an equal number of times (to
avoid statistical biases) [48].
An uphill walk by iterative saturation mutagenesis at a small number of targeted residues is
feasible if the desired property is encoded by changes at the chosen sites [50]. Saturation
mutagenesis of course explores a wider range of amino acid choices, but at a much smaller
range of positions. Simultaneous saturation mutagenesis at more than one site has the benefit
of potentially identifying mutations that only work in concert. As Reetz argues [9•], an
efficient directed evolution strategy achieves the desired function with the least amount of
work. And sometimes we even know enough about that function to be able to choose the
sites to target [29,30].
The challenge of directing evolution
Even with high-quality mutant libraries and screening, not all bad enzymes can become
good ones via a simple uphill walk—that is, not every poor enzyme lies at the base of a
fitness peak. Some problems are more difficult, and coupled mutations might be necessary
for the desired functional changes. Beneficial mutations are rare, but combinations of
beneficial mutations that only work together are even rarer. While making targeted libraries
[9•] may help, it is not clear that we know how to choose the amino acids to target. Enzymes
have been found to populate an ensemble of conformational states, and each can contribute
differently to catalysis if the active site residues are perturbed [51]. It is likely that not all
protein folds are ideal for catalyzing desired reactions. Some starting points might require
major changes (perhaps even to the protein architecture) in order to improve catalysis, and
these changes are not accessible by directed evolution.
Acknowledgments
CAT was supported by Ruth M Kirschstein National Research Service Award F32 GM076964 and NIH grant R01
GM074712-01A1. We also acknowledge support from the Institute for Collaborative Biotechnologies, the Jacobs
Institute for Molecular Medicine, and the Department of Energy.
References and recommended reading
Papers of particular interest published within the period of review have been highlighted as:
• of special interest
•• of outstanding interest
Tracewell and Arnold Page 6
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
1. Weinreich DM, Delaney NF, Depristo MA, Hartl DL. Darwinian evolution can follow only very
few mutational paths to fitter proteins. Science 2006;312:111–114. [PubMed: 16601193]
2. Poelwijk FJ, Kiviet DJ, Weinreich DM, Tans SJ. Empirical fitness landscapes reveal accessible
evolutionary paths. Nature 2007;445:383–386. [PubMed: 17251971]
3. Poelwijk FJ, Kiviet DJ, Tans SJ. Evolutionary potential of a duplicated repressor-operator pair:
simulating pathways using mutation data. PLoS Comput Biol 2006;2:e58. [PubMed: 16733549]
4•. Reetz MT, Puls M, Carballeira JD, Vogel A, Jaeger KE, Eggert T, Thiel W, Bocola M, Otte N.
Learning from directed evolution: further lessons from theoretical investigations into cooperative
mutations in lipase enantioselectivity. Chembiochem 2007;8:106–112. [PubMed: 17133645] The
authors reexamine a variant containing six mutations identified in an earlier study. They
confirmed previous computational predictions experimentally and demonstrated that only two
substitutions contributed to the change in enantioselectivity
5. Yokoyama S, Tada T, Zhang H, Britt L. Elucidation of phenotypic adaptations: molecular analyses
of dim-light vision proteins in vertebrates. Proc Natl Acad Sci U S A 2008;105:13480–13485.
[PubMed: 18768804]
6. Weinreich DM, Watson RA, Chao L. Perspective: sign epistasis and genetic constraint on
evolutionary trajectories. Evolution 2005;59:1165–1174. [PubMed: 16050094]
7. Khersonsky O, Roodveldt C, Tawfik DS. Enzyme promiscuity: evolutionary and mechanistic
aspects. Curr Opin Chem Biol 2006;10:498–508. [PubMed: 16939713]
8. O'Loughlin TL, Patrick WM, Matsumura I. Natural history as a predictor of protein evolvability.
Protein Eng Des Sel 2006;19:439–442. [PubMed: 16868005]
9•. Reetz MT, Kahakeaw D, Lohmer R. Addressing the numbers problem in directed evolution.
Chembiochem 2008;9:1797–1804. [PubMed: 18567049] This paper compares libraries
constructed from NNK codons (32 codons/20 aa) to libraries having reduced codon degeneracy
composed of NDT codons (12 codons/12 aa). The reduced library complexity yields a higher
frequency of positive hits
10. Jackel C, Kast P, Hilvert D. Protein design by directed evolution. Annu Rev Biophys 2008;37:153–
173. [PubMed: 18573077]
11. Bershtein S, Tawfik DS. Advances in laboratory evolution of enzymes. Curr Opin Chem Biol
2008;12:151–158. [PubMed: 18284924]
12. Wong TS, Roccatano D, Schwaneberg U. Steering directed protein evolution: strategies to manage
combinatorial complexity of mutant libraries. Environ Microbiol 2007;9:2645–2659. [PubMed:
17922750]
13. Landwehr M, Hochrein L, Otey CR, Kasrayan A, Backvall JE, Arnold FH. Enantioselective alpha-
hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome
P450 BM-3. J Am Chem Soc 2006;128:6058–6059. [PubMed: 16669674]
14. Bloom JD, Romero PA, Lu Z, Arnold FH. Neutral genetic drift can alter promiscuous protein
functions, potentially aiding functional evolution. Biol Direct 2007;2:17. [PubMed: 17598905]
15. Gupta RD, Tawfik DS. Directed enzyme evolution via small and effective neutral drift libraries.
Nat Methods 2008;5:939–942. [PubMed: 18931667]
16. Fischbach MA, Clardy J. One pathway, many products. Nat Chem Biol 2007;3:353–355.
[PubMed: 17576415]
17. Umeno D, Tobias AV, Arnold FH. Diversifying carotenoid biosynthetic pathways by directed
evolution. Microbiol Mol Biol Rev 2005;69:51–78. [PubMed: 15755953]
18••. O'Maille PE, Malone A, Dellas N, Andes Hess B Jr, Smentek L, Sheehan I, Greenhagen BT,
Chappell J, Manning G, Noel JP. Quantitative exploration of the catalytic landscape separating
divergent plant sesquiterpene synthases. Nat Chem Biol 2008;4:617–623. [PubMed: 18776889]
This paper examines how nine naturally occurring amino acid substitutions in a pair of synthases
affect the product spectrum. The authors analyze the product distributions of 418 out of the 512
possible variants containing a subset of these mutations. Quantitative comparisons indicate
context dependence of mutations. Single amino acid substitutions can significantly alter the
product distribution, demonstrating the evolvable nature of these secondary metabolic pathway
enzymes
Tracewell and Arnold Page 7
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
19. Trefzer A, Jungmann V, Molnar I, Botejue A, Buckel D, Frey G, Hill DS, Jorg M, Ligon JM, et al.
Biocatalytic conversion of avermectin to 4″-oxo-avermectin: Improvement of cytochrome P450
monooxygenase specificity by directed evolution. Appl Env Microbiol 2007;73:4317–4325.
[PubMed: 17483257]
20. van Vugt-Lussenburg BMA, Stjernschantz E, Lastdrager J, Oostenbrink C, Vermeulen NPE,
Commandeur JNM. Identification of critical residues in novel drug metabolizing mutants of
cytochrome P450BM3 using random mutagenesis. J Med Chem 2007;50:455–461. [PubMed:
17266197]
21. Kurtovic S, Moden O, Shokeer A, Mannervik B. Structural determinants of glutathione
transferases with azathioprine activity identified by DNA shuffling of alpha class members. J Mol
Biol 2008;375:1365–1379. [PubMed: 18155239]
22. Damian-Almazo JY, Moreno A, Lopez-Munguia A, Soberon X, Gonzalez-Munoz F, Saab-Rincon
G. Enhancement of the alcoholytic activity of alpha-amylase AmyA from Thermotoga maritima
MSB8 (DSM 3109) by site-directed mutagenesis. Appl Environ Microbiol 2008;74:5168–5177.
[PubMed: 18552192]
23. Sterner R, Hocker B. Catalytic versatility, stability, and evolution of the (betaalpha)8-barrel
enzyme fold. Chem Rev 2005;105:4038–4055. [PubMed: 16277370]
24. Li C, Hassler M, Bugg TD. Catalytic promiscuity in the alpha/beta-hydrolase superfamily:
hydroxamic acid formation, C-C bond formation, ester and thioester hydrolysis in the C-C
hydrolase family. Chembiochem 2008;9:71–76. [PubMed: 18058773]
25. Bartsch S, Kourist R, Bornscheuer UT. Complete inversion of enantioselectivity towards
acetylated tertiary alcohols by a double mutant of a Bacillus subtilis esterase. Angew Chem Int Ed
2008;47:1508–1511.
26. Chen Z, Zhao H. Rapid creation of a novel protein function by in vitro coevolution. J Mol Biol
2005;348:1273–1282. [PubMed: 15854660]
27. Reetz MT, Wang LW, Bocola M. Directed evolution of enantioselective enzymes: iterative cycles
of CASTing for probing protein-sequence space. Angew Chem Int Ed 2006;45:1236–1241.
28. Herman A, Tawfik DS. Incorporating synthetic oligonucleotides via gene reassembly (ISOR): a
versatile tool for generating targeted libraries. Protein Eng Des Sel 2007;20:219–226. [PubMed:
17483523]
29. Varadarajan N, Georgiou G, Iverson BL. An engineered protease that cleaves specifically after
sulfated tyrosine. Angew Chem Int Ed 2008;47:7861–7863.
30. Varadarajan N, Rodriguez S, Hwang BY, Georgiou G, Iverson BL. Highly active and selective
endopeptidases with programmed substrate specificities. Nat Chem Biol 2008;4:290–294.
[PubMed: 18391948]
31••. Fasan R, Chen MM, Crook NC, Arnold FH. Engineered alkanehydroxylating cytochrome
P450(BM3) exhibiting nativelike catalytic properties. Angew Chem Int Ed 2007;46:8414–
8418.This works demonstrates the progressive challenge approach to evolving an enzyme for a
substrate not accepted by the wild-type enzyme. Furthermore, positive selection for activity on
propane was sufficient to generate a highly specific enzyme. Unlike most engineered cytochrome
P450s, utilization of NADPH in the evolved enzyme is fully coupled to substrate oxidation, a
result of evolutionary optimization of all three domains. The properties of the intermediates along
the evolutionary trajectory are described in reference [43]
32. Vedha-Peters K, Gunawardana M, Rozzell JD, Novick SJ. Creation of a broad-range and highly
stereoselective D-amino acid dehydrogenase for the one-step synthesis of D-amino acids. J Am
Chem Soc 2006;128:10923–10929. [PubMed: 16910688]
33. Escalettes F, Turner NJ. Directed evolution of galactose oxidase: generation of enantioselective
secondary alcohol oxidases. Chembiochem 2008;9:857–860. [PubMed: 18330849]
34. Bershtein S, Goldin K, Tawfik DS. Intense neutral drifts yield robust and evolvable consensus
proteins. J Mol Biol 2008;379:1029–1044. [PubMed: 18495157]
35. Peisajovich SG, Tawfik DS. Protein engineers turned evolutionists. Nat Methods 2007;4:991–994.
[PubMed: 18049465]
Tracewell and Arnold Page 8
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
36. Landwehr M, Carbone M, Otey CR, Li Y, Arnold FH. Diversification of catalytic function in a
synthetic family of chimeric cytochrome P450s. Chem Biol 2007;14:269–278. [PubMed:
17379142]
37•. Rothlisberger D, Khersonsky O, Wollacott AM, Jiang L, DeChancie J, Betker J, Gallaher JL,
Althoff EA, Zanghellini A, Dym O, et al. Kemp elimination catalysts by computational enzyme
design. Nature 2008;453:190–195. [PubMed: 18354394] Computational enzyme design
generated a `bad' enzyme that was made significantly `better' by multiple rounds of directed
evolution, clearly demonstrating the power of combining these approaches. While a variety of
scaffolds were tested for incorporation of this new activity, the (ba) barrel was the most effective
and most evolvable
38. Jiang L, Althoff EA, Clemente FR, Doyle L, Rothlisberger D, Zanghellini A, Gallaher JL, Betker
JL, Tanaka F, Barbas CF 3rd, et al. De novo computational design of retro-aldol enzymes. Science
2008;319:1387–1391. [PubMed: 18323453]
39. Saravanan M, Vasu K, Nagaraja V. Evolution of sequence specificity in a restriction endonuclease
by a point mutation. Proc Natl Acad Sci U S A 2008;105:10344–10347. [PubMed: 18647833]
40•. Patrick WM, Matsumura I. A study in molecular contingency: Glutamine
phosphoribosylpyrophosphate amidotransferase is a promiscuous and evolvable
phosphoribosylanthranilate isomerase. J Mol Biol 2008;377:323–336. [PubMed: 18272177] The
authors unexpectedly found that overexpressing glutamine phosphoribosylpyrophosphate
amidotransferase (PurF) rescued a tryptophan biosynthesis deficient strain (DtrpF) missing
phosphoribosylanthranilate isomerase (PRAI) activity. The two enzymes are not homologous:
PRAI is a (βα)8-barrel whereas PurF is neither a barrel nor related mechanistically. PurF,
however, does bind phosphoribosylated substrates. Directed evolution improved the PRAI
activity in PurF 25-fold, and the cells could survive with near wild-type fitness under the
conditions tested, even though the enzyme was >107-fold less efficient than wild-type PRAI
41. Kurtovic S, Runarsdottir A, Emren LO, Larsson AK, Mannervik B. Multivariate-activity mining
for molecular quasi-species in a glutathione transferase mutant library. Protein Eng Des Sel
2007;20:243–256. [PubMed: 17468114]
42. Nair NU, Zhao H. Evolution in reverse: engineering a D-xylosespecific xylose reductase.
Chembiochem 2008;9:1213–1215. [PubMed: 18383056]
43•. Fasan R, Meharenna YT, Snow CD, Poulos TL, Arnold FH. Evolutionary history of a specialized
P450 propane monooxygenase. J Mol Biol 2008;383:1069–1080. [PubMed: 18619466] Substrate
specificity profiles of intermediates along the evolutionary path from wild-type P450 BM3 to the
propane-hydroxylating variant (identified in reference [31••]) are compared on C2-C10 alkanes.
Evolution for high activity on propane was achieved at the cost of activity on the native fattyacid
substrates and even on slightly larger alkanes
44. Bolt A, Berry A, Nelson A. Directed evolution of aldolases for exploitation in synthetic organic
chemistry. Arch Biochem Biophys 2008;474:318–330. [PubMed: 18230325]
45. Carballeira JD, Krumlinde P, Bocola M, Vogel A, Reetz MT, Backvall JE. Directed evolution and
axial chirality: optimization of the enantioselectivity of Pseudomonas aeruginosa lipase towards
the kinetic resolution of a racemic allene. Chem Commun (Camb) 2007:1913–1915. [PubMed:
17695227]
46. Bloom JD, Labthavikul ST, Otey CR, Arnold FH. Protein stability promotes evolvability. Proc
Natl Acad Sci U S A 2006;103:5869–5874. [PubMed: 16581913]
47. Williams GJ, Zhang C, Thorson JS. Expanding the promiscuity of a natural-product
glycosyltransferase by directed evolution. Nat Chem Biol 2007;3:657–662. [PubMed: 17828251]
48. Liao J, Warmuth MK, Govindarajan S, Ness JE, Wang RP, Gustafsson C, Minshull J. Engineering
proteinase K using machine learning and synthetic genes. BMC Biotechnol 2007;7:16. [PubMed:
17386103]
49. Fox RJ, Davis SC, Mundorff EC, Newman LM, Gavrilovic V, Ma SK, Chung LM, Ching C, Tam
S, Muley S, et al. Improving catalytic function by ProSAR-driven enzyme evolution. Nat
Biotechnol 2007;25:338–344. [PubMed: 17322872]
50. Reetz MT, Carballeira JD. Iterative saturation mutagenesis (ISM) for rapid directed evolution of
functional enzymes. Nat Protoc 2007;2:891–903. [PubMed: 17446890]
Tracewell and Arnold Page 9
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
51. Rissin DM, Gorris HH, Walt DR. Distinct and long-lived activity states of single enzyme
molecules. J Am Chem Soc 2008;130:5349–5353. [PubMed: 18318491]
Tracewell and Arnold Page 10
Curr Opin Chem Biol. Author manuscript; available in PMC 2009 June 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Directed evolution of enzyme activity on a new substrate often proceeds via a `generalist'
that shows weak activity on multiple substrates. Evolution of a specific enzyme from a
generalist can be done with positive selection for the new activity and negative selection to
remove those variants having the undesired activity. Specificity can also be achieved by
positive selection alone, if the solution to high activity on one substrate precludes high
activity on others.
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Figure 2.
Hypothetical evolutionary trajectories following an uphill walk to the desired fitness. Single
amino acid substitutions corresponding to an increase in fitness are indicated by an arrow.
(The much larger numbers of neutral and deleterious mutations are not shown.) More than
one sequence can have the desired fitness, and multiple paths lead to those sequences.
Restricting the number of amino acid positions that are varied or the number of different
amino acids sampled at each position, however, may lead to dead ends (filled circles). A
dead end is also reached when the protein is no longer stable enough to accept new
mutations. Further improvements from these dead ends may become accessible once the
protein is stabilized.
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